AKT1 and breast cancer: Experimental results demonstrated that Eupafolin significantly inhibited the growth of breast cancer by the PI3K/AKT, MAPKs and NF-κB pathways, causing S-phase arrest, inhibiting angiogenesis and promoting apoptosis, which was partially mediated by Cav-1.